HIV 1 News and Research

RSS

ZAMSTAR project reduces prevalence of tuberculosis by 22%

The results of a large-scale community-randomized trial presented at the 42nd World Conference on Lung Health in Lille, France today show that the Zambia-South Africa TB and AIDS Reduction (ZAMSTAR) project reduced the prevalence of tuberculosis by 22%.

31 Oct 2011

USAID celebrates 50 years of partnership with Kenya

This post in USAID's "IMPACTblog" -- the third of a four-part series on USAID's partnership with Kenya -- reports on how "USAID's health and population program ... works with partners in Kenya to bring health workers directly to the communities. These health workers provide information and care through HIV/AIDS and malaria programs, as well as work with community religious leaders to discuss family planning."

29 Oct 2011

Global Health Technologies Coalition blog reports on health research projects in Kenya

In a post in the Global Health Technologies Coalition's "Breakthroughs" blog, GHTC's Kim Lufkin reports on her travels to Kenya this month "to visit global health research projects and see the impact on people in the country," writing, "Although we visited a range of projects, I was left with the lasting impression that much of this research is so close to producing new health tools that can lead to amazing innovations in public health," including "the first ever malaria vaccine, gels women can use to protect themselves from HIV, and new drugs for neglected diseases that affect the poorest of the poor."

29 Oct 2011

Researcher's compound disables bacteria instead of killing them

After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval. A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, why not disarm them, quashing disease without the worry of antibiotic resistance?

29 Oct 2011

Scientists identify nicotinamidase enzyme as new drug target for Leishmaniasis

IRD scientist and their research partners recently identified the key role of nicotinamidase, an enzyme in the parasite Leishmania, essential for its survival but which does not exist in humans. The pathogen is incapable of developing in mammals In the absence of this enzyme. Specific targeting of this enzyme could lead to more effective ways of controlling this neglected tropical disease.

29 Oct 2011

NYUCN to study 'Test and Linkage to Care Among Injecting Drug Users Kenya'

New York University College of Nursing (NYUCN) received a five-year, $4,161,665.00 grant from the National Institute of Health's National Institute on Drug Abuse (NIH/NIDA) to research "Test and Linkage to Care Among Injecting Drug Users (TLC_IDU) Kenya."

29 Oct 2011

NYUCN to study 'Combination HIV Prevention for Kenyan Youth'

New York University College of Nursing (NYUCN) received a four-year, $ 2.8M grant from the National Institute of Health's National Institute of Allergy and Infectious Diseases (NIH/NIAID) to study "Combination HIV Prevention for Kenyan Youth."

29 Oct 2011

NIH awards NYUCN $7.56M grant to study HIV risk among heterosexuals

New York University College of Nursing (NYUCN) received a five-year, $7.56 million grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) to evaluate the efficacy and cost-effectiveness of a peer-driven intervention to seek out heterosexuals at high risk for HIV in their communities, test them for HIV, and link them to care in a timely fashion if they are found to be HIV infected.

29 Oct 2011

Merck third quarter global sales increase 8% to $12.0 billion

Merck, known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2011.

29 Oct 2011

Atwater collection of AIDS education posters now available online

When Edward Atwater, M.D., boarded a subway car on Boston's Red Line in the early 90s, he found himself staring at a poster unlike any he had seen before. It showed two hands, a condom wrapper, and text reading, "Prevent AIDS. Use One." Intrigued by what he saw, Atwater began to track how different societies viewed and responded to the worldwide epidemic through posters and other public messages, eventually gathering together the largest collection of AIDS posters in the world.

28 Oct 2011

International community must help women fight HIV/AIDS in Swaziland

Women living with HIV in Swaziland "fight a tireless tripartite battle against HIV, the stigma it places on them, and their inferior status in Africa's last absolute monarchy," freelance journalist Gary Nunn writes in the Guardian's "Poverty Matters Blog."

28 Oct 2011

U.N. report calls for investment in health, education as world population approaches 7 billion

"Instead of worrying about sheer numbers when the world's population hits seven billion next week, we should think about how to make the planet a better place for people to live in, the United Nations said" in its report, "The State of World Population 2011," released Wednesday, Reuters reports.

28 Oct 2011

IFPA event to raise awareness of psoriasis on Oct. 29

Psoriasis can be a truly devastating disease, as it not only affects your health but can also have a severe impact on how you live your life. Many people with psoriasis experience social stigmatization and discrimination on a more or less daily basis, in a wide range of settings; at school, at work, at the gym, in public bath houses.

28 Oct 2011

Foreign aid investment saves millions of lives, reflects American leadership

Chris Collins, vice president and director of public policy at the Foundation for AIDS Research (amfAR), and Khai Hoan Tram, an Allan Rosenfield Fellow at amfAR, write in this Huffington Post opinion piece that what's missing from the discussion of foreign aid -- which accounts for approximately one percent of the U.S. national budget -- "is the fact that [it] is actually used to aid those in need while advancing our country's humanitarian and diplomatic goals.

28 Oct 2011

Gilead submits Quad NDA to FDA for treatment of HIV-1 infection

Gilead Sciences, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of the "Quad", a complete single-tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults.

28 Oct 2011

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Bristol-Myers Squibb Company and Gilead Sciences, Inc. today announced a licensing agreement for Bristol-Myers Squibb to develop and commercialize a fixed-dose combination containing Bristol-Myers Squibb's protease inhibitor REYATAZ (atazanavir sulfate) and Gilead's cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain HIV medicines to potentially allow for one pill once daily dosing.

27 Oct 2011

State roundup: Ohio voters will determine public employee benefits

On Nov. 8, Ohio voters will decide the fate of the law, which allows public employees to bargain for wages and working conditions but prohibits strikes. Workers will also have to pay for healthcare insurance and pensions. The law is on hold pending the referendum.

27 Oct 2011

Study examines Global Fund's resource allocation decisions for HIV programs

A study published Wednesday in the Journal of the International AIDS Society assessed how the Global Fund to Fight AIDS, Tuberculosis and Malaria's "investments in HIV programs were targeted to key populations in relation to disease burden and national income," concluding, "There has been a sustained scale up of the Global Fund's support to HIV programs.

27 Oct 2011

Gardasil vaccine safe and effective against anal cancer

A large, international clinical trial led by doctors at the University of California, San Francisco indicates that a vaccine to prevent anal cancer is safe and effective, according to a study reported in the Oct. 27, 2011 issue of New England Journal of Medicine.

27 Oct 2011

Disconnecting global AIDS from reproductive health stalled efforts to expand family planning services, UNFPA head says

Babatunde Osotimehin, the executive director of the U.N. Population Fund (UNPFA), said in an interview with the Guardian that "efforts to expand family planning services in the developing world stalled for a decade while global health organizations turned their energies to fighting HIV/AIDS. 'We made a mistake. We disconnected HIV from reproductive health. We should never have done that because it is part and parcel,' he said."

27 Oct 2011